Rosalind Advisors as of June 30, 2025
Portfolio Holdings for Rosalind Advisors
Rosalind Advisors holds 37 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Delcath Sys Com New (DCTH) | 15.6 | $33M | 3.3M | 10.00 | |
| Fennec Pharmaceuticals (FENC) | 8.1 | $17M | 2.0M | 8.30 | |
| Cytokinetics Com New (CYTK) | 6.3 | $13M | 400k | 33.04 | |
| Ocular Therapeutix (OCUL) | 5.4 | $11M | 1.2M | 9.28 | |
| Ideaya Biosciences (IDYA) | 5.1 | $11M | 511k | 21.02 | |
| Xeris Pharmaceuticals (XERS) | 4.8 | $10M | 2.2M | 4.67 | |
| Miragen Therapeutics (VRDN) | 4.6 | $9.8M | 700k | 13.98 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.5 | $9.5M | 100k | 94.58 | |
| Verastem Com New (VSTM) | 4.0 | $8.5M | 2.0M | 4.15 | |
| Replimune Group (REPL) | 4.0 | $8.4M | 900k | 9.29 | |
| Mediwound Shs New (MDWD) | 3.7 | $7.9M | 407k | 19.37 | |
| Myomo Com New (MYO) | 3.7 | $7.8M | 3.6M | 2.16 | |
| Rezolute Com New (RZLT) | 3.7 | $7.8M | 1.7M | 4.46 | |
| Urogen Pharma (URGN) | 3.5 | $7.4M | 542k | 13.70 | |
| Cybin Com New (CYBN) | 3.2 | $6.8M | 811k | 8.39 | |
| Savara (SVRA) | 2.9 | $6.1M | 2.7M | 2.28 | |
| Inspiremd (NSPR) | 2.5 | $5.2M | 2.3M | 2.27 | |
| Cg Oncology (CGON) | 2.4 | $5.0M | 193k | 26.00 | |
| Profound Med Corp Com New (PROF) | 1.9 | $4.1M | 692k | 5.90 | |
| Pharvaris N V (PHVS) | 1.9 | $3.9M | 224k | 17.60 | |
| Polypid (PYPD) | 1.6 | $3.4M | 976k | 3.53 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.3 | $2.7M | 420k | 6.49 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $1.8M | 158k | 11.30 | |
| Inmune Bio Put Put Option | 0.8 | $1.8M | 1.0M | 1.71 | |
| Trevi Therapeutics (TRVI) | 0.8 | $1.6M | 300k | 5.47 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.6 | $1.4M | 483k | 2.80 | |
| Talphera Com New (TLPH) | 0.4 | $922k | 2.0M | 0.46 | |
| Biofrontera Com New (BFRI) | 0.3 | $695k | 976k | 0.71 | |
| Urogen Pharma Call Call Option | 0.3 | $600k | 100k | 6.00 | |
| Kura Oncology (KURA) | 0.3 | $577k | 100k | 5.77 | |
| Spdr Series Trust Put Put Option | 0.3 | $534k | 550k | 0.97 | |
| Replimune Group Call Call Option | 0.2 | $516k | 232k | 2.22 | |
| Spdr S&p 500 Etf Tr Put Put Option | 0.2 | $433k | 250k | 1.73 | |
| Atyr Pharma Put Put Option | 0.1 | $271k | 223k | 1.22 | |
| Ovid Therapeutics (OVID) | 0.1 | $165k | 500k | 0.33 | |
| Ideaya Biosciences Call Call Option | 0.0 | $68k | 20k | 3.40 | |
| Crinetics Pharmaceuticals In Call Call Option | 0.0 | $58k | 53k | 1.10 |
